The National Football League (NFL) announced Novartis as its first-ever corporate pharmaceutical partner on March 13.

The Swiss pharma giant – which has its U.S. headquarters in East Hanover – said it aims to encourage football fans to "proactively manage their health." ...

The two organizations will work together to promote healthy choices, such as early screenings. The NFL named Novartis as its first-in-category corporate pharmaceutical partner. Together, the two ...

Novartis was announced as an official partner of this year’s Eurovision competition last fall, after the song entry from ...

After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.

In other recent news, Novartis has announced a significant partnership with the National Football League (NFL), marking the league’s first official collaboration with a pharmaceutical company.

The Kooyong Classic has welcomed tennis legend and former Wimbledon champion Pat Cash as an official ambassador for the ...

On Wednesday, Novartis gave a more detailed look at long-awaited clinical data that the company believes will help secure a broad approval for a successor drug to its blockbuster gene therapy ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Phase III study showed sustained proteinuria reduction at one yea ...

ZURICH, March 19 (Reuters) - Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse panels for U.S. hiring, the latest companies ...